Article (Scientific journals)
Inhibiteurs du cotransporteur du glucose SGLT2 renal pour traiter le diabete de type 2.
SCHEEN, André; Radermecker, Régis; Ernest, Philippe et al.
2011In Revue Médicale Suisse, 7 (306), p. 1621-4, 1626-9
Peer Reviewed verified by ORBi
 

Files


Full Text
sglt2rms.pdf
Publisher postprint (637.09 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Benzhydryl Compounds; Diabetes Mellitus, Type 2/drug therapy; Glucosides/pharmacology/therapeutic use; Humans; Sodium-Glucose Transport Proteins/antagonists & inhibitors
Abstract :
[en] Kidney plays a role in glucose homeostasis, not only by its capacity to produce glucose through local gluconeogenesis, but also, and even more important in presence of diabetes, by its capacity to excrete glucose in urine when hyperglycaemia exceeds tubular reabsorption threshold. Such reabsorption depends on sodium-glucose cotransporters-2 (SGLT2), which can be blocked by selective inhibitors. These pharmacological agents augment glucosuria and reduce hyperglycaemia independently of insulin. Some have already proven their efficacy to improve glucose control, in monotherapy or in combination, while promoting weight loss and without inducing hypoglycaemia. Dapagliflozin should be the first medication of this new pharmacological class to be commercialized for the management of type 2 diabetes.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
SCHEEN, André  ;  Centre Hospitalier Universitaire de Liège - CHU > Service de diabétologie, nutrition, maladies métaboliques
Radermecker, Régis ;  Université de Liège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Ernest, Philippe ;  Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Pharmacologie clinique
Jandrain, Bernard ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de diabétologie, nutrition, maladies métaboliques
Language :
French
Title :
Inhibiteurs du cotransporteur du glucose SGLT2 renal pour traiter le diabete de type 2.
Alternative titles :
[en] Renal SGLT2 inhibitors, new agents for the management of type 2 diabetes
Publication date :
2011
Journal title :
Revue Médicale Suisse
ISSN :
1660-9379
Publisher :
Medecine et Hygiène, Switzerland
Volume :
7
Issue :
306
Pages :
1621-4, 1626-9
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 04 May 2016

Statistics


Number of views
232 (4 by ULiège)
Number of downloads
239 (2 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi